CBD/melatonin co-administration was associated with reduced feelings of anxiety, pain, depression, panic, and paranoia, as well as with “good general health perceptions.”
Topic: CBD
Of the products analyzed, CBD-infused beverage products were most likely to contain CBD percentages that differed from their labels.
Thirty-six percent of older patients decreased their use of opioids, while 20 percent reduced their use of benzodiazepines.
Based on the study’s findings, investigators concluded, “Using lower doses of CBD and trace THC seems to be promising in managing behavioral problems associated with autism.”
Scientists concluded, “Our novel findings support the possible therapeutic role of inhaled CBD as an effective, relatively safe, and easy to administer treatment adjunct for GBM.”
Researchers reported that the repeated use of oral CBD products was not associated with liver abnormalities, including the elevated production of certain liver enzymes.
Researchers observed “no symptoms of impairment” and “no significant impact on driving ability” in study subjects who inhaled CBD-dominant cigarettes.
Researchers identified “an antipsychotic medication sparing effect of CBD-cigarettes as adjunctive therapy in acutely psychotic patients.”